Clinical trial
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
NCT00004831 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 1996
- Completion date
- July 31, 1998
- Enrollment
- 20
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
erythropoietic protoporphyria